|
FY2025
12 months to Dec 28, 2025
|
FY2024
12 months to Dec 29, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Jan 1, 2023
|
FY2021
12 months to Jan 2, 2022
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Asset Impairment Charges | |||||
| Restructuring costs | |||||
| Operating income (loss) | |||||
| Interest expense | |||||
| Gain on forgiveness of PPP Loan | |||||
| Interest income and other (expense) income, net | |||||
| Income (loss) from continuing operations before income taxes | |||||
| (Benefit from) provision for income taxes | |||||
| Net income (loss) from continuing operations | |||||
| Net income (loss) from discontinued operations, net of taxes | |||||
| Net income (loss) | |||||
| Net income (loss) from continuing operations per share: (1) | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average shares: (1) | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...